Cerclage After Full Dilatation Caesarean Section (CRAFT)

An Investigation Into the Role of Previous in Labour Caesarean Section in Future Preterm Birth Risk and Management Strategies

CRAFT-OBS: Observational Study; To evaluate subsequent pregnancy risk of preterm birth in women with a history of previous caesarean in established labour. This prospective study using clinically acquired cervical length and quantitative fetal fibronectin data will help establish a predictive model of preterm birth <34 weeks and <37 weeks.

CRAFT-RCT: Randomised controlled trial arm; To assess treatment for short cervix in women at high risk of preterm birth following a caesarean section at full dilatation

CRAFT-IMG: Imaging sub-study; To aid understanding of micro and macrostructural features within the cervix which predisposes to preterm birth in women with a previous full dilatation caesarean section. This will use MRI and an advanced transvaginal ultrasound protocol and to assess if structural changes can be visualised in the cervix.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

1000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Michael Waring
  • Phone Number: michael.waring@kcl.ac.uk

Study Locations

      • London, United Kingdom, SE1 7EH
        • Recruiting
        • Guy's and St Thomas' Hospital NHS Foundation Trust
        • Contact:
          • Agnieszka Glazewska-Hallin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

CRAFT-OBS

Inclusion Criteria:

  • Pregnant women under 23+6 weeks gestation with a history of previous caesarean section in labour.
  • Singleton pregnancy.
  • Willing and able to give informed consent (with or without interpreter).

Exclusion Criteria:

  • Under 16 years of age.
  • Inability to give informed consent.
  • Previous caesarean section carried out before labour.
  • Women who have been commenced on management with progesterone, a cerclage or arabin pessary as part of their care or another research study

CRAFT-RCT:

Inclusion criteria:

  • Pregnant women up to 23+6 weeks gestation with a history of FDCS.
  • Short cervix (<=25mm) on transvaginal ultrasound scan.

Exclusion criteria:

  • Women with persistent fresh vaginal bleeding evident on speculum examination.
  • Women with visible fetal membranes evident on speculum examination or open cervix on ultrasound scan.
  • Women with severe abdominal pain/evidence of sepsis (as judged by attending clinician).
  • Known significant congenital or structural or chromosomal fetal abnormality.
  • Suspected or proven rupture of the fetal membranes at the time of recruitment.

CRAFT-IMG

Inclusion criteria:

  • Pregnant women between 14+0 and 23+6 weeks gestation with a history of FDCS.

Exclusion criteria:

  • Contraindications to MRI, e.g. claustrophobia, BMI >40 kg/m2 (due to technical limitations of scanner) or a women with a non-MRI compatible metallic implant.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Transvaginal cerclage
Transvaginal cerclage is inserted in women with a high risk of preterm birth. However it is unknown whether this alongside cervical length monitoring improves the incidence of preterm birth. The cerclage is inserted under regional analgesia.
No Intervention: Active monitoring

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
CRAFT-OBS: Number of participants with spontaneous preterm birth rate < 37 weeks gestation
Time Frame: Up to 42 weeks
Up to 42 weeks
CRAFT-RCT: Number of participants with spontaneous preterm birth <34 weeks gestation
Time Frame: Up to 42 weeks
Up to 42 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CRAFT-OBS: Short-term pregnancy and neonatal outcomes, including a composite of neonatal death and morbidity.
Time Frame: Up to 48 weeks
We will assess the number of antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services.
Up to 48 weeks
CRAFT-OBS: Number of participants with adverse perinatal outcome, defined as a composite outcome of death (antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services)
Time Frame: Up to 48 weeks
Up to 48 weeks
CRAFT-OBS: Number of participants who deliver <34 weeks gestation
Time Frame: Up to 42 weeks
Up to 42 weeks
CRAFT-OBS: Gestation at delivery
Time Frame: Up to 42 weeks
The proportion of participants who delivery at each gestation of completed weeks
Up to 42 weeks
CRAFT-OBS: Late miscarriage (14+0-23+6 weeks) rate
Time Frame: Up to 42 weeks
Up to 42 weeks
CRAFT-OBS: Any cervical length measurements taken antenatally
Time Frame: Up to 42 weeks
Up to 42 weeks
CRAFT-OBS: Number of antenatal hospital appointments
Time Frame: Up to 42 weeks
Up to 42 weeks
CRAFT-OBS: Number of hospital admissions
Time Frame: Up to 42 weeks
Up to 42 weeks
CRAFT-OBS: cervicovaginal fetal fibronectin protein levels taken at any gestation if taken
Time Frame: Up to 42 weeks
Up to 42 weeks
CRAFT-OBS: Number of ultrasound indicated antenatal interventions
Time Frame: Up to 42 weeks
Up to 42 weeks
CRAFT-OBS: Predictive modelling (QUIPP app) to evaluate the ability of CL and fFN to determine risk of preterm birth <34 and <37 weeks
Time Frame: Up to 42 weeks
Up to 42 weeks
CRAFT-OBS: Number of participants with other maternal and fetal morbidities, as per COPOP core outcome set for preterm birth intervention studies
Time Frame: Up to 48 weeks
COPOP core outcomes
Up to 48 weeks
CRAFT-RCT: Number of participants with an adverse perinatal outcome
Time Frame: Up to 48 weeks
Up to 48 weeks
CRAFT-RCT: Gestation at delivery
Time Frame: Up to 42 weeks
Proportion of participants who deliver at each gestation of completed weeks
Up to 42 weeks
CRAFT-RCT: Number of women needing insertion of a rescue cerclage (done when membranes exposed or bulging)
Time Frame: Up to 30 weeks
Up to 30 weeks
CRAFT-RCT: Time between intervention and delivery.
Time Frame: Up to 42 weeks
Up to 42 weeks
CRAFT-RCT - Health costs at 28 days post-delivery.
Time Frame: Up to 48 weeks
Up to 48 weeks
CRAFT-IMG: Evidence of cervical injury
Time Frame: Up to 40 weeks
Size of any cervical lesion and its location seen on MRI or ultrasound scans
Up to 40 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 2, 2019

Primary Completion (Anticipated)

April 1, 2022

Study Completion (Anticipated)

October 1, 2022

Study Registration Dates

First Submitted

September 26, 2019

First Submitted That Met QC Criteria

September 27, 2019

First Posted (Actual)

October 1, 2019

Study Record Updates

Last Update Posted (Actual)

July 28, 2021

Last Update Submitted That Met QC Criteria

July 27, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Study Data/Documents

  1. Study Protocol
    Information identifier: IRAS 261294

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Birth

Clinical Trials on Insertion of transvaginal cerclage

3
Subscribe